DK1173198T3 - Anvendelse af en bestemt hyaluronidase til eliminering af ar på, uigennemsigtighed og uklarhed på hornhinden - Google Patents

Anvendelse af en bestemt hyaluronidase til eliminering af ar på, uigennemsigtighed og uklarhed på hornhinden

Info

Publication number
DK1173198T3
DK1173198T3 DK00928486T DK00928486T DK1173198T3 DK 1173198 T3 DK1173198 T3 DK 1173198T3 DK 00928486 T DK00928486 T DK 00928486T DK 00928486 T DK00928486 T DK 00928486T DK 1173198 T3 DK1173198 T3 DK 1173198T3
Authority
DK
Denmark
Prior art keywords
corneal
elimination
cornea
scars
disorganization
Prior art date
Application number
DK00928486T
Other languages
English (en)
Inventor
Hampar Karageozian
Original Assignee
Ista Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ista Pharmaceuticals Inc filed Critical Ista Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1173198T3 publication Critical patent/DK1173198T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cereal-Derived Products (AREA)
DK00928486T 1999-04-29 2000-04-28 Anvendelse af en bestemt hyaluronidase til eliminering af ar på, uigennemsigtighed og uklarhed på hornhinden DK1173198T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13155899P 1999-04-29 1999-04-29
PCT/US2000/011369 WO2000066139A2 (en) 1999-04-29 2000-04-28 Biochemical methods that eliminate corneal scars, opacification and haze

Publications (1)

Publication Number Publication Date
DK1173198T3 true DK1173198T3 (da) 2004-04-13

Family

ID=22449978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00928486T DK1173198T3 (da) 1999-04-29 2000-04-28 Anvendelse af en bestemt hyaluronidase til eliminering af ar på, uigennemsigtighed og uklarhed på hornhinden

Country Status (13)

Country Link
US (1) US6737075B2 (da)
EP (1) EP1173198B1 (da)
JP (1) JP2002543143A (da)
AT (1) ATE254471T1 (da)
AU (1) AU4672300A (da)
CA (1) CA2370504A1 (da)
DE (1) DE60006660T2 (da)
DK (1) DK1173198T3 (da)
ES (1) ES2209877T3 (da)
HK (1) HK1045645A1 (da)
MX (1) MXPA01011025A (da)
PT (1) PT1173198E (da)
WO (1) WO2000066139A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7061237B2 (en) * 2000-07-13 2006-06-13 The Regents Of The University Of California Remote NMR/MRI detection of laser polarized gases
EP1324767B1 (en) * 2000-10-13 2009-06-24 The Johns Hopkins University Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery
US6902548B1 (en) * 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
US7156859B2 (en) 2001-07-23 2007-01-02 Fos Holding S.A. Device for separating the epithelium layer from the surface of the cornea of an eye
JP3921375B2 (ja) * 2001-10-12 2007-05-30 株式会社ニデック 眼科装置及び角膜手術装置
GB2389123B (en) * 2002-05-29 2005-08-17 Unilever Plc Rechargeable dispensing device
US7767429B2 (en) 2003-03-05 2010-08-03 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US7703919B2 (en) * 2003-03-28 2010-04-27 Digital Vision, Llc Application of neuro-ocular wavefront data in vision correction
WO2005023159A1 (en) * 2003-09-05 2005-03-17 Sightrate B.V. Device for separation of corneal epithelium
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
AU2006201459B2 (en) * 2005-04-08 2012-08-09 Theodore Coroneo Minas Corneal shaping
WO2007120457A2 (en) * 2006-04-13 2007-10-25 Euclid Systems Corporation Composition and method for stabilizing corneal tissue after refractive surgery
JP4871024B2 (ja) * 2006-05-26 2012-02-08 スター・ジャパン株式会社 眼内挿入用レンズの挿入器具
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
ES2994608T3 (en) 2012-08-10 2025-01-27 Osio Corp D/B/A Yolia Health Contact lens use in the treatment of an ophthalmologic condition
WO2015073397A1 (en) 2013-11-13 2015-05-21 Thixos Llc Devices, kits and methods relating to treatment of facet joints
CN105079809A (zh) * 2015-07-09 2015-11-25 广州赛莱拉干细胞科技股份有限公司 组合物、制剂、制剂的制备方法、应用及使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US5788957A (en) * 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
DK0983084T3 (da) * 1997-05-22 2007-05-07 Ista Pharmaceuticals Inc Anvendelse af hyaluronidase til fremstilling af et öjenpræparat til flydendegörelse af glaslegemet i behandlingen af öjenlidelser

Also Published As

Publication number Publication date
US20020119141A1 (en) 2002-08-29
HK1045645A1 (zh) 2002-12-06
WO2000066139A2 (en) 2000-11-09
CA2370504A1 (en) 2000-11-09
ATE254471T1 (de) 2003-12-15
MXPA01011025A (es) 2002-11-07
ES2209877T3 (es) 2004-07-01
DE60006660T2 (de) 2004-09-30
WO2000066139A3 (en) 2001-03-08
DE60006660D1 (de) 2003-12-24
EP1173198A2 (en) 2002-01-23
AU4672300A (en) 2000-11-17
US6737075B2 (en) 2004-05-18
JP2002543143A (ja) 2002-12-17
PT1173198E (pt) 2004-04-30
EP1173198B1 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
PT1173198E (pt) Utilizacao de uma determinada hialuronidase para eliminar as cicatrizes a opacificacao e a nevoa corneais
Ayala et al. Treatment of laser in situ keratomileusis interface epithelial ingrowth with neodymium: yytrium–aluminum–garnet laser
Hernández-Verdejo et al. Porcine model to compare real-time intraocular pressure during LASIK with a mechanical microkeratome and femtosecond laser
Ibrahim Laser in situ keratomileusis for hyperopia and hyperopic astigmatism
BR9808282A (pt) Liberação controlada de produtos farmacêuticos na câmara anterior do olho
MX2010006566A (es) Metodo para cirugia refractiva intraestromal.
DE69634414D1 (de) Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie
DE60126435D1 (de) Apparat zur behandlung von presbyopie und anderer augenerkrankungen mit faser-gekoppelten lasern
BR9714079A (pt) Microcerátomo
Kapadia et al. Transepithelial photorefractive keratectomy for treatment of thin flaps or caps after complicated laser in situ keratomileusis
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
Lane et al. Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap
Amoils Photorefractive keratectomy using a scanning-slit laser, rotary epithelial brush, and chilled balanced salt solution
Seiler et al. Erbium: YAG laser photoablation of human cornea
Bilgihan et al. Fluorometholone-Lnduced cataract after photoref ractive keratectomy
Fichte et al. Ongoing results of excimer laser photorefractive keratectomy for myopia: subjective patient impressions
Fraenkel et al. Paradoxical response to photorefractive treatment for postkeratoplasty astigmatism
RU94036823A (ru) Способ хирургической коррекции аномалии рефракции глаза
Vossmerbaeumer Application principles of excimer lasers in ophthalmology
Pathak et al. Femtosecond Lasers and Laser Assisted in Situ Keratomileusis (LASIK)
US6146405A (en) Ophthalmic applanator
RU2189209C1 (ru) Модифицированный способ проведения лазерного кератомилеза
Iester et al. Excimer laser PRK and nerve fiber layer thickness measurements
WO1998029069A3 (en) Method for changing the refractive power of an eye
Yoshino et al. Residual amounts of ophthalmic viscosurgical devices on the corneal endothelium following phacoemulsification